Discontinued — last reported Q4 '22
Biogen Interest Income increased by 19.9% to $37.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 58.6%, from $23.90M to $37.90M. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher interest income suggests a strong cash position or a favorable interest rate environment for the company's investments.
Interest income is the revenue earned from cash deposits, marketable securities, and other interest-bearing investments....
Varies based on cash management strategies; companies with large cash piles will report higher interest income than those with high debt.
interest_income| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.70M | $2.60M | $2.90M | $12.60M | $23.90M | $80.90M | $75.90M | $95.90M | $17.40M | $20.10M | $11.60M | $23.90M | $32.30M | $31.60M | $37.90M |
| QoQ Change | — | -3.7% | +11.5% | +334.5% | +89.7% | +238.5% | -6.2% | +26.4% | -81.9% | +15.5% | -42.3% | +106.0% | +35.1% | -2.2% | +19.9% |
| YoY Change | — | — | — | +366.7% | +819.2% | >999% | +502.4% | +301.3% | -78.5% | -73.5% | -87.9% | +37.4% | +60.7% | +172.4% | +58.6% |